CS logo
small CS logo
University of Southern California

Los Angeles, California, United States
Private university in Los Angeles, California
Los Angeles, CA 90007

About University of Southern California


The University of Southern California is a private research university in Los Angeles, California. Founded in 1880 by Robert M. Widney, it is the oldest private research university in California.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at University of Southern California


During the past decade, University of Southern California conducted 368 clinical trials. In the 10-year time frame, 368 clinical trials started and 155 clinical trials were completed, i.e. on average, 42.1% percent of trials that started reached the finish line to date. In the past 5 years, 165 clinical trials started and 94 clinical trials were completed. i.e. 57% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Southern California" #1 sponsor was "University of Southern California" with 134 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 16 trials sponsored, "National Cancer Institute (NCI)" with 14 trials sponsored, "Janssen Research & Development, LLC" with 12 trials sponsored and "University of California, San Diego" with 12 trials sponsored. Other sponsors include 435 different institutions and companies that sponsored additional 286 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Southern California" #1 collaborator was "University of Southern California" with 37 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 28 trials as a collaborator, "National Institute on Aging (NIA)" with 18 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 16 trials as a collaborator and "University of California, Los Angeles" with 13 trials as a collaborator. Other collaborators include 666 different institutions and companies that were collaborators in the rest 377 trials.

Clinical Trials Conditions at University of Southern California


According to Clinical.Site data, the most researched conditions in "University of Southern California" are "HIV Infections" (17 trials), "Alzheimer Disease" (14 trials), "Heart Failure" (14 trials), "Stroke" (14 trials) and "Breast Cancer" (13 trials). Many other conditions were trialed in "University of Southern California" in a lesser frequency.

Clinical Trials Intervention Types at University of Southern California


Most popular intervention types in "University of Southern California" are "Drug" (319 trials), "Device" (103 trials), "Other" (81 trials), "Behavioral" (65 trials) and "Biological" (49 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (69 trials), "placebo" (11 trials), "Nivolumab" (8 trials), "laboratory biomarker analysis" (8 trials) and "Gemcitabine" (7 trials). Other intervention names were less common.

Clinical Trials Genders at University of Southern California


The vast majority of trials in "University of Southern California" are 573 trials for "All" genders, 32 trials for "Female" genders and 21 trials for "Male" genders.

Clinical Trials Status at University of Southern California


Currently, there are 185 active trials in "University of Southern California". 3 are not yet recruiting, 122 are recruiting, 50 are Active, not recruiting, and 10 are Enrolling by invitation. In total, there were 332 completed trials in University of Southern California, 11 suspended trials, and 66 terminated clinical trials to date.
Out of the total trials that were conducted in University of Southern California, 78 "Phase 1" clinical trials were conducted, 159 "Phase 2" clinical trials and 130 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 36 trials, and there were also 164 trials that are defined as “Not Applicable".

Departments of University of Southern California


University of Southern California has several departments that took part in Clinical trials: "USC Norris Comprehensive Cancer Center" - 1151 trials, "USC Norris Oncology/Hematology-Newport Beach" - 67 trials, "LAC / USC Med Ctr / Infectious Diseases" - 6 trials, "Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine" - 6 trials, "USC Department of Radiology" - 5 trials, "USC Health Sciences Center Dept of Genetics-Site Number:840082" - 4 trials, "USC Department of Neurological Surgery" - 4 trials, "USC/Kenneth Norris Comprehensive Cancer Center Regulatory Contact 3" - 3 trials, "Clinical Biomechanics Orthopedic and Sports Outcomes Research Laboratory" - 2 trials, "University of Southern California" - 2 trials, "USC Westside Prostate Cancer Center" - 2 trials, "University of Southern California, Department of Neurology" - 2 trials, "USC Westside Center for Diabetes" - 2 trials, "University of Southern California - Healthcare Consultation Center" - 2 trials, "Infant Neuromotor Control Laboratory" - 2 trials, "University of Southern California - Alzheimer Disease Research Center - Healthcare Consultation Center II" - 2 trials, "University of Southern California Atherosclerosis Research Unit" - 2 trials, "Keck Medicine of USC- Division of Rheumatology" - 2 trials, "University of Southern California - Infectious Diseases" - 2 trials